Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Trainer

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
European Journal of Endocrinology|February 27, 2007
Pegvisomant interference in GH assays results in underestimation of GH levelsA N Paisley, K Hayden, A Ellis, et al.
The Journal of Endocrinology|September 1, 1992
Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormoneP J Trainer, J M Kirk, M O Savage, et al.
Clinical Endocrinology|April 18, 2007
Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practiceA Pokrajac, G Wark, A R Ellis, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Clinical Endocrinology|October 1, 1993
The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndromeP J Trainer, C Eastment, A B Grossman, et al.
Nuclear Medicine Communications|July 1, 1992
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)K K Solanki, J Bomanji, J Moyes, et al.
Clinical Endocrinology|April 10, 2002
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegalyC Parkinson, W M Drake, G Wieringa, et al.
Clinical Endocrinology|December 11, 2008
Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD)C A Berg, A Pokrajac, M Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Complications of inferior petrosel sinus samplingG A Kaltsas, J D Newell-Price, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
European Journal of Endocrinology|February 27, 2007
Pegvisomant interference in GH assays results in underestimation of GH levelsA N Paisley, K Hayden, A Ellis, et al.
The Journal of Endocrinology|September 1, 1992
Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormoneP J Trainer, J M Kirk, M O Savage, et al.
Clinical Endocrinology|April 18, 2007
Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practiceA Pokrajac, G Wark, A R Ellis, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Clinical Endocrinology|October 1, 1993
The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndromeP J Trainer, C Eastment, A B Grossman, et al.
Nuclear Medicine Communications|July 1, 1992
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)K K Solanki, J Bomanji, J Moyes, et al.
Clinical Endocrinology|April 10, 2002
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegalyC Parkinson, W M Drake, G Wieringa, et al.
Clinical Endocrinology|December 11, 2008
Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD)C A Berg, A Pokrajac, M Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Complications of inferior petrosel sinus samplingG A Kaltsas, J D Newell-Price, P J Trainer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Pageof 11